1. © Coherent market Insights. All Rights Reserved BIOSIMILAR PIPELINE ANALYSIS MARKET Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025 © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Biosimilar is a type of biological product that is almost identical to the original product, which has undergone patent expiration. Development and validation of biosimilars are an important part of the overall production process. Regulation for biosimilar drugs plays an important role in maintaining the efficiency and balance between original and biosimilar drugs. There are various authorities such as U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA), which regulate the development and commercialization of biosimilars. Biosimilar drugs are available at relatively low prices as compared to patented drugs without compromising on efficacy. Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/582 https://www.coherentmarketinsights.com/insight/request-sample/582 Biosimilar has a complex structure, multi-layer manufacturing and immunogenicity risk due to which they require unique regulatory pathways for introduction in the market. Biosimilar ensures treatment of diseases considered to be incurable such as cancer and autoimmune disorders, they are developed independently and have same mechanism of action as patented drugs for the specific disease. There are different stages involved in the development of biosimilars such as product development, process development, clinical trial and regulatory approval and review. Biosimilar Pipeline Analysis Market Overview

3. © Coherent market Insights. All Rights Reserved Biosimilar pipeline analysis market taxonomy: By Product Type Human Growth Hormone Insulin Interferon Peptides Monoclonal antibodies Others By Services Clinical Trials Contract Research and Manufacturing Request a Customization: https://www.coherentmarketinsights.com/insight/request-customization/582 https://www.coherentmarketinsights.com/insight/request-customization/582 REPORT DESCRIPTION

4. © Coherent market Insights. All Rights Reserved REPORT DESCRIPTION Patent expiration and low pricing is expected to fuel the biosimilar pipeline analysis market Biosimilar market is under the initial phase of development, they are used for the treatment of various disorders such as autoimmune disease, cancer as per National Institute of Health 2012 report, there were more than 23.5 million people living with autoimmune disease in the U.S. and low pricing of biosimilar drugs make them affordable for people. The same mechanism of action provides effective treatment for disease along with increased awareness among people are expected to fuel the growth of biosimilar pipeline market. Various companies and their R&D departments such as Pfizer Inc., Zydus Cadila are involved in the development of biosimilar, which is under clinical trial. Pfizer’s biosimilar clinical stage pipeline includes five monoclonal antibodies fare under clinical trial phase I to phase 3 which will be used for the treatment of autoimmune disease and oncology. Key players of biosimilar pipeline analysis market There are various players present across the world and competing with each other extensively in the market to attain maximum share. Companies are also involved in R&D to increase the biosimilar pipeline. Some key players are Biocon, Pfizer Inc., F. Hoffmann-La Roche Ltd, Amgen Inc., Kyowa Pharmaceutical Industry Co. Ltd, Boehringer Ingelheim GmbH, AstraZeneca, Novartis AG, and Merck & Co. Get Exclusive Discount on this CMI Report: https://www.coherentmarketinsights.com/insight/request-discount/582 https://www.coherentmarketinsights.com/insight/request-discount/582

5. © Coherent market Insights. All Rights Reserved Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. ABOUT US ABOUT COHERENT MARKET INSIGHTS SERVICES INDUSTRY ANALYSIS CUSTOMIZED RESEARCH SYNDICATED RESEARCH CONSULT STUDIES MARKET INTELLIGENCE SERVICES COUNTRY SPECIFIC STUDIES

6. © Coherent market Insights. All Rights Reserved  Global Leading Equipment and System Manufacturers  Component Providers and System Integrators  Distributors, Retailors and Value Added Resellers  Healthcare IT Solutions Developers  Marketing Consultancies and the Advertising Industry  Private and Government organization  Outsourcing Companies  Universities and Business Schools. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGYCLINICAL DIAGNOSTICHEALTHCARE IT PHARMACEUTICALMEDICAL IMAGINGMEDICAL DEVICES OUR CLIENTS

7. © Coherent market Insights. All Rights Reserved Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. ABOUT US RESEARCH SOLUTIONS GLOBAL REPORTS FEASIBILITY STUDIES TECHNOLOGY SNIPPETS EXCEL FORECAST DATABASE COMPETITIVE ASSESSMENT SURVEY RESEARCH CUSTOMIZED SOLUTIONS CONSULT PROJECTS COUNTRY ANALYSIS KEY STATS Insights Published Per Year Consulting Projects Till Date Clients Worldwide Per Year Analysts and Contract Consultants 100+ 150+ 125+ 110+

8. © Coherent market Insights. All Rights Reserved THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702